Cantor Fitzgerald Initiates Coverage On ProMIS Neurosciences with Overweight Rating
Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on ProMIS Neurosciences (NASDAQ: PMN ) with a Overweight rating.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.